Bristol Myers joins AstraZeneca in agreeing to drug price negotiation terms ahead of first deadline

Pharma companies are now reluctantly agreeing to participate in the Center for Medicare and Medicaid Services’ first round of negotiations for 10 drugs.

Ahead of a key Oct. 1 deadline, both Bristol Myers Squibb and AstraZeneca have now said they will participate in the negotiations with CMS, although nearly all…
Click here to view original post